Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis

Lech, 2013, The pathogenesis of lupus nephritis, J Am Soc Nephrol, 24, 1357, 10.1681/ASN.2013010026 Munoz, 2010, The role of defective clearance of apoptotic cells in systemic autoimmunity, Nat Rev Rheumatol, 6, 280, 10.1038/nrrheum.2010.46 Hakkim, 2010, Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis, Proc Natl Acad Sci U S A, 107, 9813, 10.1073/pnas.0909927107 Marshak-Rothstein, 2007, Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease, Annu Rev Immunol, 25, 419, 10.1146/annurev.immunol.22.012703.104514 Migliorini, 2012, A novel pathogenetic concept-antiviral immunity in lupus nephritis, Nat Rev Nephrol, 8, 183, 10.1038/nrneph.2011.197 Hiepe, 2011, Long-lived autoreactive plasma cells drive persistent autoimmune inflammation, Nat Rev Rheumatol, 7, 170, 10.1038/nrrheum.2011.1 Chung, 2014, Lupus nephritis susceptibility loci in women with systemic lupus erythematosus, J Am Soc Nephrol, 25, 2859, 10.1681/ASN.2013050446 Lennon, 2015, Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease, Pediatr Nephrol, 30, 1459, 10.1007/s00467-015-3067-9 Papazachariou, 2014, Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing, PLoS One, 9, e115015, 10.1371/journal.pone.0115015 Lech, 2011, IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production, J Am Soc Nephrol, 22, 1443, 10.1681/ASN.2010121260 Anders, 2014, Immunopathology of lupus nephritis, Semin Immunopathol, 36, 443, 10.1007/s00281-013-0413-5 Linkermann, 2014, Regulated cell death and inflammation: an auto-amplification loop causes organ failure, Nat Rev Immunol, 14, 759, 10.1038/nri3743 Yu, 2013, Neutrophil extracellular traps and systemic lupus erythematosus, J Clin Cell Immunol, 4 Han, 2014, Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression, Eur J Immunol, 44, 215, 10.1002/eji.201343714 Brinkmann, 2004, Neutrophil extracellular traps kill bacteria, Science, 303, 1532, 10.1126/science.1092385 Cheng, 2015, Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis, Int J Rheum Dis, 18, 533, 10.1111/1756-185X.12433 Zhang, 2014, Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus, Intern Med, 53, 2763, 10.2169/internalmedicine.53.2570 Smith, 2014, Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus, Arthritis Rheum, 66, 2532, 10.1002/art.38703 Knight, 2013, Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus, J Clin Invest, 123, 2981, 10.1172/JCI67390 Knight, 2014, Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice, Ann Rheum Dis Campbell, 2012, NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus, Sci Transl Med, 4, 157ra41, 10.1126/scitranslmed.3004801 Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis, Nat Med, 15, 623, 10.1038/nm.1959 Nakazawa, 2012, Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis, Arthritis Rheum, 64, 3779, 10.1002/art.34619 Kumar, 2015, Neutrophil extracellular trap-related extracellular histones cause vascular necrosis in severe GN, J Am Soc Nephrol, 10.1681/ASN.2014070673 Carmona-Rivera, 2015, Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2, Ann Rheum Dis, 74, 1417, 10.1136/annrheumdis-2013-204837 MacDonald, 2002, Characterization of human blood dendritic cell subsets, Blood, 100, 4512, 10.1182/blood-2001-11-0097 Mackern-Oberti, 2015, Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases, Autoimmun Rev, 14, 127, 10.1016/j.autrev.2014.10.010 Palombo, 2013, Therapeutic implications of immunogenic cell death in human cancer, Front Immunol, 4, 503 Villadangos, 2008, Antigen-presentation properties of plasmacytoid dendritic cells, Immunity, 29, 352, 10.1016/j.immuni.2008.09.002 Wang, 2014, Bruton’s tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells, Eur J Immunol, 44, 1130, 10.1002/eji.201344030 Anders, 2010, Interferon-alpha and -beta in kidney inflammation, Kidney Int, 77, 848, 10.1038/ki.2010.71 Rowland, 2014, Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model, J Exp Med, 211, 1977, 10.1084/jem.20132620 Davison, 2015, Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice, Arthritis Rheum, 67, 1012, 10.1002/art.38989 Zhan, 2015, Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-alpha production, Arthritis Rheum, 67, 797, 10.1002/art.38966 Sisirak, 2014, Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus, J Exp Med, 211, 1969, 10.1084/jem.20132522 Teichmann, 2010, Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage, Immunity, 33, 967, 10.1016/j.immuni.2010.11.025 Teichmann, 2013, Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus, Immunity, 38, 528, 10.1016/j.immuni.2012.11.017 Lamagna, 2013, Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation, Proc Natl Acad Sci U S A, 110, E3311, 10.1073/pnas.1300617110 Gleisner, 2013, Dendritic and stromal cells from the spleen of lupic mice present phenotypic and functional abnormalities, Mol Immunol, 54, 423, 10.1016/j.molimm.2013.01.011 Carreno, 2009, Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc gamma receptors and costimulatory molecules on dendritic cells, Immunology, 128, 334, 10.1111/j.1365-2567.2009.03138.x Clatworthy, 2014, FcgammaRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis, Proc Natl Acad Sci U S A, 111, 17971, 10.1073/pnas.1413915111 Rupanagudi, 2015, Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming, Ann Rheum Dis, 74, 452, 10.1136/annrheumdis-2013-203717 Yang, 2007, Interaction between antigen presenting cells and autoreactive T cells derived from BXSB mice with murine lupus, Cell Res, 17, 556, 10.1038/sj.cr.7310146 Gaspal, 2011, Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice, J Exp Med, 208, 1579, 10.1084/jem.20101484 Chiba, 2012, Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1, Nat Immunol, 13, 832, 10.1038/ni.2376 Maurya, 2014, Immunoregulation of dendritic cells by the receptor T cell Ig and mucin protein-3 via Bruton’s tyrosine kinase and c-Src, J Immunol, 193, 3417, 10.4049/jimmunol.1400395 Wu, 2015, Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function, Clin Immunol, 156, 43, 10.1016/j.clim.2014.10.011 Liu, 2014, Lupus nephritis: from pathogenesis to targets for biologic treatment, Nephron Clin Pract, 128, 224, 10.1159/000368581 Andreoli, 2015, A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus, Lupus, 24, 499, 10.1177/0961203314559089 Sahu, 2014, Structure and function of renal macrophages and dendritic cells from lupus-prone mice, Arthritis Rheumatol, 66, 1596, 10.1002/art.38410 Fiore, 2008, Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis, Mol Immunol, 45, 259, 10.1016/j.molimm.2007.04.029 Patole, 2005, G-rich DNA suppresses systemic lupus, J Am Soc Nephrol, 16, 3273, 10.1681/ASN.2005060658 Pawar, 2006, Toll-like receptor-7 modulates immune complex glomerulonephritis, J Am Soc Nephrol, 17, 141, 10.1681/ASN.2005070714 Pawar, 2007, Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus, J Am Soc Nephrol, 18, 1721, 10.1681/ASN.2006101162 Anders, 2004, Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice, FASEB J, 18, 534, 10.1096/fj.03-0646fje Lech, 2007, Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells, Kidney Int, 72, 182, 10.1038/sj.ki.5002293 Allam, 2008, The role of innate immunity in autoimmune tissue injury, Curr Opin Rheumatol, 20, 538, 10.1097/BOR.0b013e3283025ed4 Christensen, 2006, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity, 25, 417, 10.1016/j.immuni.2006.07.013 Savarese, 2008, Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis, Arthritis Rheum, 58, 1107, 10.1002/art.23407 Anders, 2008, Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus, Eur J Immunol, 38, 1795, 10.1002/eji.200838478 Subramanian, 2006, A Tlr7 translocation accelerates systemic autoimmunity in murine lupus, Proc Natl Acad Sci U S A, 103, 9970, 10.1073/pnas.0603912103 Deane, 2007, Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation, Immunity, 27, 801, 10.1016/j.immuni.2007.09.009 Zhuang, 2014, Toll-like receptor 7-stimulated tumor necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus, Arthritis Rheumatol, 66, 140, 10.1002/art.38189 Kanno, 2015, Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases, Nat Commun, 6, 6119, 10.1038/ncomms7119 Ramirez-Ortiz, 2015, The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity, Nat Immunol, 16, 495, 10.1038/ni.3143 Kelley, 2007, Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects, Arthritis Rheum, 56, 3375, 10.1002/art.22916 Garcia-Ortiz, 2010, Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population, Ann Rheum Dis, 69, 1861, 10.1136/ard.2009.124313 Shen, 2010, Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus, Proc Natl Acad Sci U S A, 107, 15838, 10.1073/pnas.1001337107 Lyn-Cook, 2014, Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs, Mol Immunol, 61, 38, 10.1016/j.molimm.2014.05.001 Kawasaki, 2011, TLR7 single-nucleotide polymorphisms in the 3′ untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study, Arthritis Res Ther, 13, R41, 10.1186/ar3277 Wang, 2014, Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population, Sci Rep, 4, 3792, 10.1038/srep03792 Jackson, 2014, Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation, J Immunol, 192, 4525, 10.4049/jimmunol.1400098 Summers, 2010, TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy, J Autoimmun, 35, 291, 10.1016/j.jaut.2010.05.004 Nickerson, 2010, TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus, J Immunol, 184, 1840, 10.4049/jimmunol.0902592 Desnues, 2014, TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice, Proc Natl Acad Sci U S A, 111, 1497, 10.1073/pnas.1314121111 Fukui, 2011, Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking, Immunity, 35, 69, 10.1016/j.immuni.2011.05.010 Fukui, 2009, Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing, J Exp Med, 206, 1339, 10.1084/jem.20082316 Klonowska-Szymczyk, 2014, Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus, Mediators Inflamm, 2014, 381418, 10.1155/2014/381418 Chauhan, 2013, Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation, J Clin Immunol, 33, 954, 10.1007/s10875-013-9887-0 Tsao, 2012, Altered IL-10 and TNF-alpha production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation, Clin Exp Med, 12, 153, 10.1007/s10238-011-0161-6 Capolunghi, 2010, Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients, Rheumatology (Oxford), 49, 2281, 10.1093/rheumatology/keq226 Patole, 2005, Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells, J Am Soc Nephrol, 16, 1326, 10.1681/ASN.2004100820 Sadanaga, 2007, Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice, Arthritis Rheum, 56, 1618, 10.1002/art.22571 Annable, 2015, Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus, Autoimmunity, 48, 29, 10.3109/08916934.2014.959166 Cervantes, 2013, Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes, J Leukoc Biol, 94, 1231, 10.1189/jlb.0413206 Diebold, 2008, Recognition of viral single-stranded RNA by Toll-like receptors, Adv Drug Deliv Rev, 60, 813, 10.1016/j.addr.2007.11.004 Heil, 2004, Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8, Science, 303, 1526, 10.1126/science.1093620 Alexopoulou, 2012, [Toll-like receptor 8: the awkward TLR], Med Sci (Paris), 28, 96, 10.1051/medsci/2012281023 Demaria, 2010, TLR8 deficiency leads to autoimmunity in mice, J Clin Invest, 120, 3651 Umiker, 2014, Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus, Eur J Immunol, 44, 1503, 10.1002/eji.201344283 Anders, 2010, Toll-like receptors and danger signaling in kidney injury, J Am Soc Nephrol, 21, 1270, 10.1681/ASN.2010030233 Anders, 2014, Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis, J Am Soc Nephrol, 25, 1387, 10.1681/ASN.2014010117 Lee, 2014, Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice, Exp Biol Med (Maywood), 239, 715, 10.1177/1535370214525299 Liu, 2006, TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease, J Immunol, 177, 6880, 10.4049/jimmunol.177.10.6880 Lartigue, 2009, Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus, J Immunol, 183, 6207, 10.4049/jimmunol.0803219 Kirchner, 2013, Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus, Pediatr Rheumatol Online J, 11, 9, 10.1186/1546-0096-11-9 Kaiser, 2014, A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus, Arthritis Rheumatol, 66, 1882, 10.1002/art.38520 Dominguez-Villar, 2015, TLR7 induces anergy in human CD4(+) T cells, Nat Immunol, 16, 118, 10.1038/ni.3036 Celhar, 2014, Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment, Front Pharmacol, 5, 265, 10.3389/fphar.2014.00265 Applequist, 2002, Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines, Int Immunol, 14, 1065, 10.1093/intimm/dxf069 Lau, 2005, RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement, J Exp Med, 202, 1171, 10.1084/jem.20050630 Leadbetter, 2002, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors, Nature, 416, 603, 10.1038/416603a Boule, 2004, Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes, J Exp Med, 199, 1631, 10.1084/jem.20031942 Hwang, 2012, B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice, J Immunol, 189, 5786, 10.4049/jimmunol.1202195 Fairhurst, 2008, Yaa autoimmune phenotypes are conferred by overexpression of TLR7, Eur J Immunol, 38, 1971, 10.1002/eji.200838138 Soni, 2014, B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers, J Immunol, 193, 4400, 10.4049/jimmunol.1401720 Zhu, 2012, The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus, PLoS One, 7, e44131, 10.1371/journal.pone.0044131 Hua, 2014, Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice, J Immunol, 192, 875, 10.4049/jimmunol.1300683 Pawar, 2006, Microbial nucleic acids pay a Toll in kidney disease, Am J Physiol Renal Physiol, 291, F509, 10.1152/ajprenal.00453.2005 Anders, 2005, Molecular mechanisms of autoimmunity triggered by microbial infection, Arthritis Res Ther, 7, 215, 10.1186/ar1818 Allam, 2009, Viral RNA and DNA trigger common antiviral responses in mesangial cells, J Am Soc Nephrol, 20, 1986, 10.1681/ASN.2008101067 Patole, 2006, Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice, Nephrol Dial Transplant, 21, 3062, 10.1093/ndt/gfl336 Timmerman, 1997, Antigen-antibody complexes enhance the production of complement component C3 by human mesangial cells, J Am Soc Nephrol, 8, 1257, 10.1681/ASN.V881257 Imaizumi, 2014, Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells, Clin Exp Nephrol Lichtnekert, 2009, Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif, Am J Physiol Renal Physiol, 296, F867, 10.1152/ajprenal.90213.2008 Ka, 2007, Mesangial cells of lupus-prone mice are sensitive to chemokine production, Arthritis Res Ther, 9, R67, 10.1186/ar2226 Svenson, 2014, Estrogen receptor alpha modulates mesangial cell responses to toll-like receptor ligands, Am J Med Sci, 348, 492, 10.1097/MAJ.0000000000000339 Kimura, 2014, Overexpression of Toll-like receptor 8 correlates with the progression of podocyte injury in murine autoimmune glomerulonephritis, Sci Rep, 4, 7290, 10.1038/srep07290 Benigni, 2007, Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus, Arthritis Rheum, 56, 1569, 10.1002/art.22524 Papadimitraki, 2009, Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response, Lupus, 18, 831, 10.1177/0961203309103054 Frieri, 2012, Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients, J Nephrol, 25, 1041, 10.5301/jn.5000091 Machida, 2010, Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis, Nephrol Dial Transplant, 25, 2530, 10.1093/ndt/gfq058 Pawar, 2009, Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier, Immunology, 128, e206, 10.1111/j.1365-2567.2008.02948.x Bezalel, 2014, Type I interferon signature in systemic lupus erythematosus, Isr Med Assoc J, 16, 246 Flur, 2009, Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: implications for viral infection-associated glomerulonephritis, Am J Pathol, 175, 2014, 10.2353/ajpath.2009.080585 Hagele, 2009, Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1, Nephrol Dial Transplant, 24, 3312, 10.1093/ndt/gfp339 Anders, 2009, Pseudoviral immunity—a novel concept for lupus, Trends Mol Med, 15, 553, 10.1016/j.molmed.2009.10.004 Funabiki, 2014, Autoimmune disorders associated with gain of function of the intracellular sensor MDA5, Immunity, 40, 199, 10.1016/j.immuni.2013.12.014 Oliveira, 2014, Dysregulation of antiviral helicase pathways in systemic lupus erythematosus, Front Genet, 5, 418, 10.3389/fgene.2014.00418 Maringer, 2014, Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection, Cytokine Growth Factor Rev, 25, 669, 10.1016/j.cytogfr.2014.08.004 Ahn, 2014, Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease, Curr Opin Immunol, 31, 121, 10.1016/j.coi.2014.10.009 Ahn, 2012, STING manifests self DNA-dependent inflammatory disease, Proc Natl Acad Sci U S A, 109, 19386, 10.1073/pnas.1215006109 Reboulet, 2010, Prolonged antigen storage endows merocytic DC with enhanced capacity to prime anti-tumor responses in tumor-bearing mice, J Immunol, 185, 3337, 10.4049/jimmunol.1001619 Klarquist, 2014, STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells, J Immunol, 193, 6124, 10.4049/jimmunol.1401869 Kawane, 2006, Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages, Nature, 443, 998, 10.1038/nature05245 Sharma, 2015, Suppression of systemic autoimmunity by the innate immune adaptor STING, Proc Natl Acad Sci U S A, 112, E710, 10.1073/pnas.1420217112 Jeremiah, 2014, Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations, J Clin Invest, 124, 5516, 10.1172/JCI79100 Kumagai, 2009, Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells, J Immunol, 182, 3960, 10.4049/jimmunol.0804315 Decembre, 2014, Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells, PLoS Pathog, 10, e1004434, 10.1371/journal.ppat.1004434 Lovgren, 2004, Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG, Arthritis Rheum, 50, 1861, 10.1002/art.20254 Kassim, 2013, Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells, Cell Immunol, 284, 119, 10.1016/j.cellimm.2013.07.017 Ko, 2013, Activation of the interferon pathway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients, Front Immunol, 4, 309, 10.3389/fimmu.2013.00309 Ronnblom, 2008, The innate immune system in SLE: type I interferons and dendritic cells, Lupus, 17, 394, 10.1177/0961203308090020 Cai, 2014, PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3, J Immunol, 192, 3383, 10.4049/jimmunol.1302411 Lindau, 2014, TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen, Ann Rheum Dis, 73, 2199, 10.1136/annrheumdis-2012-203041 Lopez, 2014, Interferon-alpha-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes, Rheumatology (Oxford), 53, 2249, 10.1093/rheumatology/keu249 Chang, 2015, Interferon-alpha induces altered transitional B cell signaling and function in systemic lupus erythematosus, J Autoimmun, 58, 100, 10.1016/j.jaut.2015.01.009 Rodriguez-Pla, 2014, IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes, J Immunol, 192, 5586, 10.4049/jimmunol.1301319 Thibault, 2009, Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus, Arthritis Res Ther, 11, R112, 10.1186/ar2771 Theofilopoulos, 2012, TLRs and IFNs: critical pieces of the autoimmunity puzzle, J Clin Invest, 122, 3464, 10.1172/JCI63835 Hron, 2004, Type I IFN protects against murine lupus, J Immunol, 173, 2134, 10.4049/jimmunol.173.3.2134 Baccala, 2012, Anti-IFN-alpha/beta receptor antibody treatment ameliorates disease in lupus-predisposed mice, J Immunol, 189, 5976, 10.4049/jimmunol.1201477 Liu, 2011, IFN-alpha confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice, J Immunol, 187, 1506, 10.4049/jimmunol.1004142 Ytterberg, 1982, Serum interferon levels in patients with systemic lupus erythematosus, Arthritis Rheum, 25, 401, 10.1002/art.1780250407 Gota, 2003, Induction of clinical autoimmune disease by therapeutic interferon-alpha, Autoimmunity, 36, 511, 10.1080/08916930310001605873 Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc Natl Acad Sci U S A, 100, 2610, 10.1073/pnas.0337679100 Pollard, 2013, Interferon-gamma and systemic autoimmunity, Discov Med, 16, 123 Petri, 2009, Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus, Lupus, 18, 980, 10.1177/0961203309105529 Petri, 2013, Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study, Arthritis Rheum, 65, 1011, 10.1002/art.37824 Hagele, 2009, Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway, Am J Pathol, 175, 1896, 10.2353/ajpath.2009.090182 Migliorini, 2013, The antiviral cytokines IFN-alpha and IFN-beta modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration, Am J Pathol, 183, 431, 10.1016/j.ajpath.2013.04.017 Fairhurst, 2008, Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice, Eur J Immunol, 38, 1948, 10.1002/eji.200837925 Fairhurst, 2009, Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis, J Immunol, 183, 6831, 10.4049/jimmunol.0900742 Zagury, 2009, IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model, Proc Natl Acad Sci U S A, 106, 5294, 10.1073/pnas.0900615106 Jorgensen, 2007, Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice, Genes Immun, 8, 653, 10.1038/sj.gene.6364430 Santiago-Raber, 2003, Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice, J Exp Med, 197, 777, 10.1084/jem.20021996 Agrawal, 2009, Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease, J Immunol, 183, 6021, 10.4049/jimmunol.0803872 Dai, 2014, Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure, Clin Immunol, 154, 66, 10.1016/j.clim.2014.06.008 Nacionales, 2007, Deficiency of the type I interferon receptor protects mice from experimental lupus, Arthritis Rheum, 56, 3770, 10.1002/art.23023 Nickerson, 2013, Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1, J Immunol, 190, 3889, 10.4049/jimmunol.1203525 Braun, 2003, Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice, J Autoimmun, 20, 15, 10.1016/S0896-8411(02)00109-9 Kono, 2013, TLRs and interferons: a central paradigm in autoimmunity, Curr Opin Immunol, 25, 720, 10.1016/j.coi.2013.10.006 Abeler-Dorner, 2013, Interferon-alpha abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis, J Rheumatol, 40, 1683, 10.3899/jrheum.121299